Pharmacogenetics and Pharmacogenomics

Pharmacogenomics refers to how the total set of qualities (the genome) will affect how people react to medications, while pharmacogenetics refers to how variation in a particular quality affects the response to a specific treatment. It is obvious that mutagenicity and cancer-causing properties are related. Understanding the specificity of mutagenic agents in microbes leads to an instant understanding of how environmental mutagenic agents contribute to the development of malignant tumors in humans.

·         Epigenetics

·         Cancer pharmacogenetics

·         Genomic therapy

·         Pharmacogenetic approach involved in modulating cell processes

·        Genome-enabled biochemistry

·         Pharmacogenomics & human genomics


    Related Conference of Pharmacogenetics and Pharmacogenomics

    February 01-02, 2024

    37th World Congress on Pharmacology

    Dubai, UAE
    February 22-23, 2024

    34th Annual European Pharma Congress

    Zurich, Switzerland
    April 04-05, 2024

    17th European Biosimilars Congress

    Madrid, Spain
    April 11-12, 2024

    5th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    May 09-10, 2024

    4th Global Summit on Pharmaceutical Research

    Barcelona, Spain
    May 16-17, 2024

    18th World Drug Delivery Summit

    Rome, Italy
    May 30-31, 2024

    9th Pharmaceutical Chemistry Conference

    Paris, France
    September 11-12, 2024

    9th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 25-26, 2024

    4th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Pharmacogenetics and Pharmacogenomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in